Annual Short Term Debt
$324.00 K
+$20.00 K+6.58%
31 December 2023
Summary:
Viking Therapeutics annual short term debt is currently $324.00 thousand, with the most recent change of +$20.00 thousand (+6.58%) on 31 December 2023. During the last 3 years, it has fallen by -$6000.00 (-1.82%). VKTX annual short term debt is now -90.61% below its all-time high of $3.45 million, reached on 31 December 2017.VKTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$480.00 K
+$146.00 K+43.71%
30 September 2024
Summary:
Viking Therapeutics quarterly short term debt is currently $480.00 thousand, with the most recent change of +$146.00 thousand (+43.71%) on 30 September 2024. Over the past year, it has increased by +$161.00 thousand (+50.47%). VKTX quarterly short term debt is now -87.10% below its all-time high of $3.72 million, reached on 31 March 2018.VKTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VKTX Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +6.6% | +50.5% |
3 y3 years | -1.8% | +317.4% |
5 y5 years | +100.0% | +62.7% |
VKTX Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -1.8% | +1017.2% | at high | +1555.2% |
5 y | 5 years | -1.8% | at high | +1555.2% | |
alltime | all time | -90.6% | -87.1% |
Viking Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $480.00 K(+43.7%) |
June 2024 | - | $334.00 K(+1.5%) |
Mar 2024 | - | $329.00 K(+1.5%) |
Dec 2023 | $324.00 K(+6.6%) | $324.00 K(+1.6%) |
Sept 2023 | - | $319.00 K(+1.6%) |
June 2023 | - | $314.00 K(+1.6%) |
Mar 2023 | - | $309.00 K(+1.6%) |
Dec 2022 | $304.00 K(+948.3%) | $304.00 K(+1.7%) |
Sept 2022 | - | $299.00 K(+25.6%) |
June 2022 | - | $238.00 K(+58.7%) |
Mar 2022 | - | $150.00 K(+417.2%) |
Dec 2021 | $29.00 K(-91.2%) | $29.00 K(-74.8%) |
Sept 2021 | - | $115.00 K(-41.9%) |
June 2021 | - | $198.00 K(-29.0%) |
Mar 2021 | - | $279.00 K(-15.5%) |
Dec 2020 | $330.00 K(+9.3%) | $330.00 K(+2.2%) |
Sept 2020 | - | $323.00 K(+2.2%) |
June 2020 | - | $316.00 K(+2.3%) |
Mar 2020 | - | $309.00 K(+2.3%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2019 | $302.00 K(>+9900.0%) | $302.00 K(+2.4%) |
Sept 2019 | - | $295.00 K(+2.4%) |
June 2019 | - | $288.00 K(+2.5%) |
Mar 2019 | - | $281.00 K(>+9900.0%) |
Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
Mar 2018 | - | $3.72 M(+7.8%) |
Dec 2017 | $3.45 M(+5.5%) | $3.45 M(+8.5%) |
Sept 2017 | - | $3.18 M(+4.3%) |
June 2017 | - | $3.05 M(-6.7%) |
Dec 2016 | $3.27 M(+974.5%) | $3.27 M(+15.7%) |
Sept 2016 | - | $2.83 M(+18.6%) |
June 2016 | - | $2.38 M(+24.7%) |
Sept 2015 | - | $1.91 M(+14.4%) |
June 2015 | - | $1.67 M(+438.2%) |
Mar 2015 | - | $310.40 K(+2.0%) |
Dec 2014 | $304.30 K(+548.8%) | $304.30 K(+4.4%) |
June 2014 | - | $291.50 K(+508.6%) |
Mar 2014 | - | $47.90 K |
Dec 2013 | $46.90 K | - |
FAQ
- What is Viking Therapeutics annual short term debt?
- What is the all time high annual short term debt for Viking Therapeutics?
- What is Viking Therapeutics annual short term debt year-on-year change?
- What is Viking Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Viking Therapeutics?
- What is Viking Therapeutics quarterly short term debt year-on-year change?
What is Viking Therapeutics annual short term debt?
The current annual short term debt of VKTX is $324.00 K
What is the all time high annual short term debt for Viking Therapeutics?
Viking Therapeutics all-time high annual short term debt is $3.45 M
What is Viking Therapeutics annual short term debt year-on-year change?
Over the past year, VKTX annual short term debt has changed by +$20.00 K (+6.58%)
What is Viking Therapeutics quarterly short term debt?
The current quarterly short term debt of VKTX is $480.00 K
What is the all time high quarterly short term debt for Viking Therapeutics?
Viking Therapeutics all-time high quarterly short term debt is $3.72 M
What is Viking Therapeutics quarterly short term debt year-on-year change?
Over the past year, VKTX quarterly short term debt has changed by +$161.00 K (+50.47%)